Vaxcyte Inc (PCVX) — Financial Flexibility Index
Vaxcyte Inc (PCVX) has a Financial Flexibility Index of -0.75x as of March 2026. Free cash flow of $-265.83 Million (operating CF $-280.62 Million minus capex $14.79 Million) represents -1% of total liabilities ($352.29 Million). Also explore net asset momentum of Vaxcyte Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vaxcyte Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Vaxcyte Inc across 9 annual periods. Check PCVX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vaxcyte Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Vaxcyte Inc. For the full company profile including market capitalisation, see PCVX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.78x | $-641.86 Million | $-655.58 Million | $360.45 Million | ▲ +14.9% |
| 2024 | -2.09x | $-430.20 Million | $-452.63 Million | $205.50 Million | ▼ -53.1% |
| 2023 | -1.37x | $-228.91 Million | $-296.79 Million | $167.45 Million | ▲ +56.4% |
| 2022 | -3.13x | $-164.76 Million | $-170.60 Million | $52.56 Million | ▼ -10.0% |
| 2021 | -2.85x | $-114.84 Million | $-121.39 Million | $40.32 Million | ▼ -194.3% |
| 2020 | -0.97x | $-45.47 Million | $-46.63 Million | $46.98 Million | ▼ -262.4% |
| 2019 | -0.27x | $-45.95 Million | $-47.15 Million | $172.07 Million | ▼ -19.6% |
| 2018 | -0.22x | $-28.69 Million | $-30.47 Million | $128.53 Million | ▼ -14022.4% |
| 2017 | 0.00x | $-13.74K | $-14.96K | $8.69 Million | — |